Find uplifting stories about heroes, innovations, and solutions
6280 results for "arthritis treatment"
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
People at high risk of rheumatoid arthritis delayed the disease by up to four years after just one year of treatment with abatacept. The breakthrough study from King's College London offers new hope for preventing an autoimmune disease before it starts.
A new clinical trial shows patients with early-stage arthritis felt better faster when they received disease-modifying drugs instead of just pain relievers. Within three months, those taking stronger medications saw noticeably less joint pain and swelling.
Scientists have developed experimental treatments that regenerated damaged joints in animal studies within weeks, potentially offering hope to millions who currently face only pain management or major surgery. Clinical trials could begin in just 18 months.
Researchers at New York's Feinstein Institutes transformed a dangerous immune trigger into a breakthrough therapy that could save lives from sepsis and rheumatoid arthritis. The treatment activates only where disease strikes, sparing healthy immune function.
Scientists discovered that semaglutide, the drug behind Ozempic and Wegovy, can rebuild damaged cartilage in people with arthritis even without weight loss. The breakthrough hints at a powerful new treatment for millions suffering from joint pain.
Stanford researchers discovered a treatment that reverses cartilage loss in aging joints and prevents arthritis from forming after injuries. The breakthrough could one day replace knee and hip surgeries for millions suffering from joint pain.
A massive study of nearly 10,000 people shows that simple, drug-free treatments like knee braces, water therapy, and exercise outperform medications for arthritis pain. These accessible options deliver real relief without the serious health risks of common pain pills.
A minimally invasive procedure delivered lasting pain relief to nearly 200 knee arthritis patients without requiring surgery or replacement. The treatment blocks inflammation-causing blood vessels and helped patients return to daily activities within weeks.
Scientists at Monash University discovered a tick protein that blocks immune signals linked to multiple sclerosis, rheumatoid arthritis, and cancer. This natural protein could lead to more effective treatments for diseases that currently have limited options.
A single year of treatment can delay rheumatoid arthritis for up to four years in high-risk patients, offering hope to half a million people in the UK living with this painful condition. The benefits lasted long after treatment stopped.
Scientists discovered that a one-year treatment can postpone the painful joint condition rheumatoid arthritis for up to four years, even after stopping the medication. The breakthrough offers hope to 400,000 people in the UK living with or at risk of developing this life-altering autoimmune disease.
Scientists discovered that a single year of treatment with abatacept can delay rheumatoid arthritis development by up to four years, even after stopping the medication. The breakthrough offers hope to 400,000 UK patients living with the painful autoimmune condition.
Scientists at Washington State University discovered why common arthritis drugs fail for 40% of patients and found a promising path to better treatments. The breakthrough reveals a "backdoor" inflammation pathway that could transform care for millions worldwide.
Researchers can now predict rheumatoid arthritis up to five years before symptoms appear, opening the door to preventing the painful disease entirely. Clinical trials are testing whether short treatments could stop the condition before it starts.
Doctors in Buffalo are reprogramming patients' immune cells to fight autoimmune diseases the same way they fight cancer. The one-time treatment could replace lifelong medications for millions living with lupus, MS, and rheumatoid arthritis.
Researchers can now detect rheumatoid arthritis up to five years before symptoms appear, opening the door to prevent the disease before it causes joint damage. Clinical trials are already testing treatments that could stop this painful condition in its tracks.
Scientists created a molecule that stops arthritis inflammation without weakening the body's ability to fight real infections. The breakthrough could help 15 million Americans manage autoimmune diseases more safely.
A common, affordable arthritis medication could become the first antiviral treatment for RSV, the leading cause of infant hospitalizations in the U.S. Early lab tests show the drug stops the virus from spreading in human respiratory cells without harming healthy tissue.
A simple daily fiber supplement reduced knee pain in arthritis patients within six weeks, offering new hope for millions living with chronic joint pain. The breakthrough connects gut health to pain relief in ways scientists are just beginning to understand.
Showing 20 of 6280